Cenexel Clinical Research Acquires Rocky Mountain Movement Disorders Center
01/11/22, 6:12 PM
Location
Industry
health care
CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Rocky Mountain Movement Disorders Center’s clinical research site operations. CenExel Rocky Mountain Clinical Research (“CenExel RMCR”) is a leading movement disorders-focused research facility in Denver, with experience spanning more than 100 clinical trial studies. The primary indications served by CenExel RMCR include Parkinson’s Disease, Huntington’s Disease, Essential Tremor, and other movement disorders.
Company Info
Location
Salt Lake City, Utah, United States
Company info
CenExel Clinical Research (www.CenExel.com) provides unparalleled medical and scientific support in the design and execution of clinical trials. Our therapeutic area focus and attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. CenExel Centers of Excellence have conducted thousands of studies, the variety and complexity of which have resulted in a vast depth of experience and insight for the Principal Investigators and research staff in each facility. The CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that their clients achieve their clinical research goals.